Review Article

Neuropharmacological Potential of Gastrodia elata Blume and Its Components

Table 1

Pathological models used to identify the effects of Gastrodia elata (GE) and its components on neurodegenerative disorders.

ModelInducerExtracts/componentsDose/route/regimenAnimal or cell Major findingReference

SeizureCocaineGE rhizome—methanol extract 500 or 1000 mg/kg, p.o., 5 times every 12 h before cocaine treatmentC57BL/6J miceSeizure onset time ↑
Seizure duration ↓
[29]
KA EFME of GE200 or 500 mg/kg, p.o., 14 days before and 4 days after KA injectionICR miceOnset time of neurobehavioral change ↑
Severity of convulsions ↓
Hippocampal neuronal damage ↓
[25]
KAGE rhizome—ethanol extract0.5 or 1.0 g/kg, p.o., 30 min before KA injectionSD ratsSeizure onset time ↑
Seizure-like behavior ↓
[24]
KAGE rhizome—aqueous extract0.5 or 1.0 g/kg, p.o., 1 week before or 2 weeks after KA injectionSD ratsThree types of seizure (wet dog shakes, paw tremor, and facial myoclonia) ↓[26]
PTZEFME of GE rhizome500 mg/kg, p.o., for 10 daysSD ratsSeizure recovery time ↓
Seizure severity ↓
[30]

IschemiaHypoxiaGastrodin25–100 μg/mLRat cortical neuronsNeuronal survival ↑[42]
MCAOGastrodin 50 mg/kg, i.p., 10 min before MCAOSD ratsInfarct volume ↓
Cerebral injury ↓
Amino acids ↑
[41]
MCAO Gastrodin50 or 100 mg/kg, i.p., at the onset of MCAOSD ratsInfarct volume ↓
Edema volume ↓
[40]
Transient global ischemia EFME of GE rhizome200 or 500 mg/kg, p.o., 14 days before brain ischemiaMongolian gerbilsNeuronal damage in hippocampal CA1 ↓[39]
Transient global ischemia Vanillin, 4-HBAL, and 4-HBA40 mg/kg, i.p., 30 min before and after ischemiaMongolian gerbilsNeuronal survival in hippocampal CA1 ↑[38]

Alzheimer’s diseaseAβ (1–42)GE rhizome—chloroform extract20 μg/mL, for 24 hPC12 and primary neuronal cellsNeuronal cell protection ↑[45]
Aβ (1–42)GE rhizome—methanol extract, gastrodin, and 4-HBA10 μg/mL, for 48 hBV2 mouse microglial cell Cell viability ↑[48]
Aβ (25–35)GE rhizome powder500 or 1000 mg/kg, p.o., for 52 daysWistar rats Amyloid deposits ↓
Spatial memory ↑
Choline acetyltransferase ↑
[47]

Parkinson’s diseaseMPP+Gastrodin1, 5, and 25 μM, 4 h prior to MPP+ exposureSH-SY5Y cellsCell viability ↑
Oxidative stress ↓
[54]
MPP+GE rhizome—ethanol extract10, 100, and 200 μg/mL, 4 h prior to MPP+ exposureSH-SY5Y cellsCell viability ↑
Cytotoxicity ↓
[53]
MPP+GE rhizome—ethanol extract
Vanillyl alcohol
10, 100, and 200 μg/mL
1, 10, and 100 μM
MN9D cellsCell viability ↑
Cytotoxicity ↓
[55]
MPTP, MPP+Gastrodin 10, 30, and 60 mg/kg, p.o., for 15 days
1, 5, and 25 μM, 4 h prior to MPP+ exposure
C57BL/6 mice,
SH-SY5Y cells
Bradykinesia ↓
Motor impairment ↓
Cell viability ↑
[52]

4-HBA: 4-hydroxybenzyl alcohol; 4-HBAL: 4-hydroxybenzaldehyde; 6-OHDA: 6-hydroxydopamine; EFME: ether fraction of methanol extract; GE: Gastrodia elata; ICR: Institute of Cancer Research; KA: kainic acid; L-DOPA: L-3,4-dihydroxyphenylalanine; MCAO: middle cerebral artery occlusion; MPP+: 1-methyl-4-phenylpyridinium; MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PC: pheochromocytoma; PTZ: pentylenetetrazole; SD: Sprague Dawley.